These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10858364)

  • 1. Direct measurement of the anti-influenza agent zanamivir in the respiratory tract following inhalation.
    Peng AW; Milleri S; Stein DS
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1974-6. PubMed ID: 10858364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zanamivir: an influenza virus neuraminidase inhibitor.
    Colman PM
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):191-9. PubMed ID: 15918777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprophylaxis of influenza A virus infections, with single doses of zanamivir, demonstrates that zanamivir is cleared slowly from the respiratory tract.
    Fenton RJ; Morley PJ; Owens IJ; Gower D; Parry S; Crossman L; Wong T
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2642-7. PubMed ID: 10543741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
    Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
    N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection.
    Calfee DP; Peng AW; Cass LM; Lobo M; Hayden FG
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1616-20. PubMed ID: 10390212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zanamivir.
    Waghorn SL; Goa KL
    Drugs; 1998 May; 55(5):721-5; discussion 725-7. PubMed ID: 9585868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase inhibitors: zanamivir and oseltamivir.
    McNicholl IR; McNicholl JJ
    Ann Pharmacother; 2001 Jan; 35(1):57-70. PubMed ID: 11197587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers.
    Cass LM; Efthymiopoulos C; Bye A
    Clin Pharmacokinet; 1999; 36 Suppl 1():1-11. PubMed ID: 10429835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza virus neuraminidase inhibitors.
    Gubareva LV; Kaiser L; Hayden FG
    Lancet; 2000 Mar; 355(9206):827-35. PubMed ID: 10711940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zanamivir: a review of clinical safety.
    Freund B; Gravenstein S; Elliott M; Miller I
    Drug Saf; 1999 Oct; 21(4):267-81. PubMed ID: 10514019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating influenza with zanamivir.
    Fleming DM
    Lancet; 1999 Feb; 353(9153):668-9. PubMed ID: 10030349
    [No Abstract]   [Full Text] [Related]  

  • 12. New influenza drugs zanamivir (Relenza) and oseltamivir (Tamiflu): unexpected serious reactions.
    Macdonald L
    CMAJ; 2000 Oct; 163(7):879-81, 883-5. PubMed ID: 11033723
    [No Abstract]   [Full Text] [Related]  

  • 13. Two neuraminidase inhibitors for treatment of influenza.
    Med Lett Drugs Ther; 1999 Oct; 41(1063):91-3. PubMed ID: 10535051
    [No Abstract]   [Full Text] [Related]  

  • 14. Zanamivir. 4-guanidino Neu5Ac2en, GG 167, GR 121167, GR 121167X, Relenza.
    Drugs R D; 1999 Sep; 2(3):178-83. PubMed ID: 10641221
    [No Abstract]   [Full Text] [Related]  

  • 15. Zanamivir: from drug design to the clinic.
    Elliott M
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1885-93. PubMed ID: 11779388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapulmonary Pharmacokinetics of Laninamivir, a Neuraminidase Inhibitor, after a Single Nebulized Administration of Laninamivir Octanoate in Healthy Japanese Subjects.
    Toyama K; Furuie H; Ishizuka H
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of zanamivir on duration and resolution of influenza symptoms.
    Monto AS; Moult AB; Sharp SJ
    Clin Ther; 2000 Nov; 22(11):1294-305. PubMed ID: 11117654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory distress associated with zanamivir.
    Williamson JC; Pegram PS
    N Engl J Med; 2000 Mar; 342(9):661-2. PubMed ID: 10702061
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuraminidase inhibitors for treatment of influenza A and B infections.
    MMWR Recomm Rep; 1999 Dec; 48(RR-14):1-9. PubMed ID: 10632443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuraminidase inhibitors as potential anti-influenza drugs.
    Bamford MJ
    J Enzyme Inhib; 1996; 10(1):1-16. PubMed ID: 8835926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.